Generation of Induced Pluripotent Stem Cell Lines from Friedreich Ataxia Patients
- 920 Downloads
Friedreich ataxia (FRDA) is an autosomal recessive disorder characterised by neurodegeneration and cardiomyopathy. It is caused by a trinucleotide (GAA) repeat expansion in the first intron of the FXN gene that results in reduced synthesis of FXN mRNA and its protein product, frataxin. We report the generation of induced pluripotent stem (iPS) cell lines derived from skin fibroblasts from two FRDA patients. Each of the patient-derived iPS (FA-iPS) cell lines maintain the GAA repeat expansion and the reduced FXN mRNA expression that are characteristic of the patient. The FA-iPS cells are pluripotent and form teratomas when injected into nude mice. We demonstrate that following in vitro differentiation the FA-iPS cells give rise to the two cell types primarily affected in FRDA, peripheral neurons and cardiomyocytes. The FA-iPS cell lines have the potential to provide valuable models to study the cellular pathology of FRDA and to develop high-throughput drug screening assays. We have previously demonstrated that stable insertion of a functional human BAC containing the intact FXN gene into stem cells results in the expression of frataxin protein in differentiated neurons. As such, iPS cell lines derived from FRDA patients, following correction of the mutated gene, could provide a useful source of immunocompatible cells for transplantation therapy.
KeywordsInduced pluripotent stem cells Friedreich ataxia Frataxin
The authors are grateful to Ms L Corben for her help in the preparation of the ethics documentation, M. Pera for provision of TG-30 and to L. Li, M. Denham and K. Upton for technical assistance and helpful discussions. This work was supported by the Friedreich Ataxia Research Association (Australasia) and Friedreich’s Ataxia Research Alliance.
All authors contributed in: conception and design, collection of data, data analysis and interpretation, manuscript writing, final approval. Financial support provided by MD and AP. The authors declare no competing financial interests relevant to this research.
FRDA-iPS cells generate beating cardiomyocytes. Generation of functional cardiomyocytes obtained following FA3-iPS derived EB plated onto gelatine and spontaneous differentiation. (MPG 8895 kb)
FRDA-iPS cells generate beating cardiomyocytes. Generation of functional cardiomyocytes obtained following FA4-iPS derived EB plated onto gelatine and spontaneous differentiation. (MPG 6509 kb)
- 9.Hu, B. Y., Weick, J. P., & Yu, J., et al. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proceedings of the National Academy of Sciences of the United States of America, 107(9), 4335–4340.Google Scholar
- 11.Tat, P. A., Sumer, H., Jones, K. L., & Verma, P. J. (2009). Immuno-modulation strategies for ESC and ASC transplantation therapy. In K. Deb (Ed.), Stem Cells: (pp. 215–244). Basics and Applications: McGraw Hill.Google Scholar
- 12.Santoro, L., Perretti, A., Lanzillo, B., et al. (2000). Influence of GAA expansion size and disease duration on central nervous system impairment in Friedreich's ataxia: contribution to the understanding of the pathophysiology of the disease. Clinical Neurophysiology, 111(6), 1023–1030.PubMedCrossRefGoogle Scholar
- 13.Fillat, C., Simonaro, C. M., Yeyati, P. L., Abkowitz, J. L., Haskins, M. E., & Schuchman, E. H. (1996). Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy. Journal of Clinical Investigation, 98(2), 497–502.PubMedCrossRefGoogle Scholar
- 20.Hotta, R., Pepdjonovic, L., Anderson, R. B., et al. (2009). Small-molecule induction of neural crest-like cells derived from human neural progenitors. Stem cells (Dayton Ohio), 27(12), 2896–2905.Google Scholar
- 40.Clark, R. M., De Biase, I., Malykhina, A. P., Al-Mahdawi, S., Pook, M., & Bidichandani, S. I. (2007). The GAA triplet-repeat is unstable in the context of the human FXN locus and displays age-dependent expansions in cerebellum and DRG in a transgenic mouse model. Human Genetics, 120(5), 633–640.PubMedCrossRefGoogle Scholar